ADHD MEDICATION TABLE FULLY SOLVED
PAPER GRADED A+
◉ Adderall.
Answer: Mixed amphetamine salts
◉ Evekeo.
Answer: Racemic amphetamine
◉ Zenzedi.
Answer: Dextroamphetamine
◉ ProCentra.
Answer: Dextroamphetamine oral solution
◉ Dexedrine Spansule.
Answer: Dextroamphetamine intermediate-acting formulation
◉ Adderall XR.
Answer: Mixed amphetamine salts extended-release capsule with
immediate and delayed release beads in a 1:1 ratio
,◉ Mydayis.
Answer: Mixed amphetamine salts triple-bead extended-release
capsule with up to 16 hours of effect
◉ Dyanavel XR.
Answer: Amphetamine extended-release suspension and chewable
tablet
◉ Vyvanse.
Answer: Lisdexamfetamine prodrug available as a capsule and
chewable tablet
◉ Xelstrym.
Answer: Dextroamphetamine transdermal patch
◉ Strattera.
Answer: Atomoxetine
◉ Qelbree.
Answer: Viloxazine
, ◉ Kapvay.
Answer: Clonidine extended-release formulation
◉ Onyda XR.
Answer: Clonidine extended-release oral suspension for patients
who cannot swallow solids
◉ Intuniv.
Answer: Guanfacine extended-release formulation
◉ ADHD DSM-5-TR presentations.
Answer: Combined presentation
◉ ADHD severity classifications.
Answer: Mild, moderate, severe
◉ ADHD symptom threshold in children.
Answer: 6 or more symptoms
◉ ADHD symptom threshold at age 17 and older.
Answer: 5 or more symptoms
PAPER GRADED A+
◉ Adderall.
Answer: Mixed amphetamine salts
◉ Evekeo.
Answer: Racemic amphetamine
◉ Zenzedi.
Answer: Dextroamphetamine
◉ ProCentra.
Answer: Dextroamphetamine oral solution
◉ Dexedrine Spansule.
Answer: Dextroamphetamine intermediate-acting formulation
◉ Adderall XR.
Answer: Mixed amphetamine salts extended-release capsule with
immediate and delayed release beads in a 1:1 ratio
,◉ Mydayis.
Answer: Mixed amphetamine salts triple-bead extended-release
capsule with up to 16 hours of effect
◉ Dyanavel XR.
Answer: Amphetamine extended-release suspension and chewable
tablet
◉ Vyvanse.
Answer: Lisdexamfetamine prodrug available as a capsule and
chewable tablet
◉ Xelstrym.
Answer: Dextroamphetamine transdermal patch
◉ Strattera.
Answer: Atomoxetine
◉ Qelbree.
Answer: Viloxazine
, ◉ Kapvay.
Answer: Clonidine extended-release formulation
◉ Onyda XR.
Answer: Clonidine extended-release oral suspension for patients
who cannot swallow solids
◉ Intuniv.
Answer: Guanfacine extended-release formulation
◉ ADHD DSM-5-TR presentations.
Answer: Combined presentation
◉ ADHD severity classifications.
Answer: Mild, moderate, severe
◉ ADHD symptom threshold in children.
Answer: 6 or more symptoms
◉ ADHD symptom threshold at age 17 and older.
Answer: 5 or more symptoms